Web Analytics

fundsforNGOs

Grants and Resources for Sustainability

You are here: Home / Innovation / Pfizer launches Competitive Grant Program for Innovative Digital Health Projects – Italy

Pfizer launches Competitive Grant Program for Innovative Digital Health Projects – Italy

Deadline: 30-Jan-25

Pfizer has launched the Competitive Grant Program for Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients.

Area of Interest
  • It is the intent to support projects that focus on improvement of quality of life of MM patients through innovative digital solutions including artificial intelligence.
  • This might include a critical look at current practice patterns and at the development of new algorithms and work processes.
  • There will be different types of digital projects that will be considered:
    • Digital projects aimed at improving patient care (for example patient management and telehealth programs.)
    • Digital projects aimed at healthcare professional (HCP) decision making support (for example diagnosis and patient management)
    • Projects, including artificial intelligence application, to enable healthcare systems being smarter, faster, and more efficient in providing care to patients.
Funding Information
  • Funding support is available up to 70,000 Euros for projects that will be completed within 24 months.
Geographic Scope
Target Audience 
  • Oncologists and other healthcare professionals involved in the care of patients with Multiple Myeloma
Eligibility Criteria
  • Only organizations are eligible to receive grants, not individuals or medical practice groups.
  • The following may apply:
    • public healthcare bodies (hospitals, Aziende Sanitarie Locali [ASLs], universities, Istituti di Ricovero e Cura a Carattere Scientifico [IRCCS] or accredited private hospitals that are involved in the care of multiple myeloma patients.
  • Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions / organizations are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
  • The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
  • The Project Lead/PI must be an employee of the requesting organization.

For more information, visit Pfizer.